APA
CTXR icon

American Portfolios Advisors’s Citius Pharmaceuticals CTXR Stock Holding History

American Portfolios Advisors’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$4.84K Hold
160
– – ﹤0.01% 2833
2022
Q2 		$3.68K Hold
160
– – ﹤0.01% 2948
2022
Q1 		$7.16K Hold
160
– – ﹤0.01% 2823
2021
Q4 		$6.16K Hold
160
– – ﹤0.01% 2814
2021
Q3 		$8.12K Hold
160
– – ﹤0.01% 2663
2021
Q2 		$13.9K Buy
+160
New +$9.62K ﹤0.01% 2366

Other funds holding CTXR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
IA
Inspire Advisors Meridian, Idaho $1.23B AUM 18.62% 1-Year Est. Return

American Portfolios Advisors's CTXR Position: Q3 2022 in Review

American Portfolios Advisors held its Citius Pharmaceuticals (CTXR) position steady in Q3 2022 at 160 shares worth $4.84K. The position accounts for ﹤0.01% of the portfolio, ranked #2833.

American Portfolios Advisors first reported a position in CTXR in Q2 2021 and has held it in 6 quarters since. The position peaked at $13.9K in Q2 2021. 56 funds tracked by Wall St. Rank hold CTXR as of Q3 2022.

  • American Portfolios Advisors held 160 shares of Citius Pharmaceuticals worth $4.84K as of Q3 2022.
  • American Portfolios Advisors left its Citius Pharmaceuticals share count unchanged in Q3 2022.
  • Citius Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2833 holding.
  • American Portfolios Advisors first reported a position in Citius Pharmaceuticals in Q2 2021 and has held it in 6 quarters since.
  • American Portfolios Advisors's Citius Pharmaceuticals position peaked at $13.9K in Q2 2021.
  • 56 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.